Rebecca Bart, PhD – genetics, molecular and computational biology to study how the environment affects the interactions between plants and microbes.

Juliane Bubeck Wardenburg, MD, PhD – fundamental principles of the interaction between bacterial pathogens including Staphylococcus aureus and the host.

Michael Caparon, PhD – interactions of pathogenic Gram-positive bacteria including Streptococcus pyogenes with their human hosts.

Gautam Dantas, PhD – dynamics, ecology, and evolution of antibiotic resistance, engineering enhanced probiotics to treat gastrointestinal disorders, and engineering microbial biofuel catalysts.

Brian Edelson, MD, PhD – how autoreactive T cells mediate autoimmune disease and activity of innate immune cells against bacterial and helminthic pathogens.

Mario Feldman, PhD – pathogenesis of multidrug resistant bacteria and biogenesis of bacterial vesicles in the human gut.

James Fleckenstein, MD – molecular investigation of enterotoxigenic Escherichia coli (ETEC).

Stephanie Fritz, MD, MSCI – asking and answering critical questions to guide clinical practice and ameliorate childhood suffering due to staphylococcal disease.

Eric Galburt, PhD – biophysical studies of transcription initiation in Eukaryotes and Mycobacterium tuberculosis.

Jeffrey Henderson, MD, PhD – biochemical interactions between humans and bacteria in health and disease.

Scott Hultgren, PhD – host-pathogen interactions, gut-bladder axis, epigenetics, structural pathogenesis, translation to new therapeutics.

David Hunstad, MD – sex differences, virulence mechanisms, and novel therapeutics in E. coli urinary tract infection.

James Janetka, PhD – rational structure-based drug design and synthesis for cancer and infectious disease.

Robert Kranz, PhD – gene regulation and biogenesis of extracellular components in bacteria.

F. Matthew Kuhlmann, MD, MSCI – pre-clinical development of rationally designed Enterotoxigenic E. coli (ETEC) vaccines.

Hrishikesh Kulkarni, MD, MSCI – modulating host-pathogen interactions—especially the complement system—to mitigate pneumonia and acute lung injury.

Barbara Kunkel, PhD – molecular genetic analysis of disease development in Pseudomonas syringae-Arabidopsis interactions.

Janet Lee, MD – host immune response to extracellular Gram-negative respiratory pathogens, pulmonary host defense and lung injury.

Michele LeRoux, PhD – the molecular arms race between bacteria and phage.

Petra Levin, PhD – bacterial growth and antibiotic susceptibility.

William McCoy, MD, PhD – how host-microbe interactions at epithelial barrier sites impact skin diseases.

Mark Miller, PhD – lymphoid tissue dynamics and antigen-presentation during infection, cancer and autoimmunity.

S. Celeste Morley, MD, PhD – cell biology of the immune system — understanding how cytoskeletal control of cell motility and adhesion impacts host immunity to infection.

Jacqueline Payton, MD, PhD – regulation of the host immune response in bacterial and viral infections and the impact on blood cancers.

Jennifer Philips, MD, PhD – immune evasion by Mycobacterium tuberculosis.

Courtney Reichhardt, PhD – investigating the fundamental biophysical principles of biofilm assembly.

Felipe Ribeiro, PhD – understanding the neuroimmune basis of infectious and non-infectious diseases.

David Rosen, MD, PhD – pathogenesis and host response to Klebsiella pneumoniae infections.

Jai Rudra, PhD – development of nano-scale biomaterials for engaging the immune system to induce protective antibody and cell-mediated immune responses against diseases.

Drew Schwartz, MD, PhD – pediatric gut microbiome and immune disruption in serious bacterial infections.

Christina Stallings, PhD – molecular pathogenesis of Mycobacterium tuberculosis.

Joan Strassmann, PhD – predator-prey interactions between bacteria and a generalist amoebal soil predator, Dictyostelium discoideum.

Siobhan Sutcliffe, PhD, ScM, MHS – infectious causes of cancer and chronic diseases.

Phillip Tarr, MD – pathogenic interactions between microbes and the gut.

Aayushi Uberoi, PhD – understanding the interplay between microbiome, host, and environment in regulating skin barrier homeostasis and pathogenesis.

Deborah Veis (Novack), MD, PhD – host:pathogen interactions in the bone microenvironment.

Meng Wu, PhD – tripartite interactions among the microbiota, stromal cells and the immune system.